INDEGENE LIMITED Share Price

₹ 586.80

-₹6.65 (-1.12%)
1D
Last updated 30 Oct, 2026, 15:53 IST
NSE: INDGN
|
Pharmaceuticals

INDEGENE LIMITED Share Price Today

As of 2 Nov 2026, INDEGENE LIMITED share price is ₹586.80. The stock opened at ₹594.00, compared to its previous close of ₹593.45. During today's trading session, INDEGENE LIMITED share price moved in the range of ₹576.95 to ₹594.00, with an average price of ₹585.48 for the day. Looking at its last 52-week, the stock has touched a low of ₹414.00 and a high of ₹627.00. On the performance front, INDEGENE LIMITED share price has increased by 17.42% over the last six months and is up 6.29% on a year-on-year basis.

Share price over the last 1 day fell from 589.10 to 585.20, ranging between 578.20 and 592.05.
₹576.95
1.12% down today
₹594.00
1D LOW
1D HIGH

INDEGENE LIMITED Stock Insights

Latest Earning
Op Profit TrendDown by 3.47% QoQ
Latest Earning
Net Profit TrendDown by 3.36% QoQ
Latest Earning
Revenue TrendUp by 4.14% QoQ
Stock Performance
OutperformingBeat Nifty by 19.37 % in last 3 month
Shareholding Pattern
DIIDII increased stake by 3.36%
Shareholding Pattern
FIIFII increased stake by 25.13%
Technical Indicators
Volume SpikeVolume is 79.0% above 20-day average on 1 Day interval.
Technical Indicators
MACD CrossThe MACD line crossed below the signal line on 1 Day interval.
INDEGENE LIMITED stock performance
Open₹594.00
High₹594.00
Low₹576.95
Prev. close₹593.45
INDEGENE LIMITED trading activity
Volume7,00,973
Average traded price₹587.20
Last traded time03:53:23 30 Oct
Last traded quantity1
Circuit
L
H
₹469.45
₹704.15
52-week
L
H
₹414.00
₹627.00
Mkt Cap Cr
14,161.95
P/E
34.45
P/B
4.22
ROA
8.76%
ROE
12.24%
ROCE
16.02%
Quick Ratio
2.41
EV/EBITDA
19.08

Based on fundamentals, this stock's

Performance: 4 out of 5, Good
Performance
Good
Indegene outperforming most market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Indegene appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Indegene earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Apollo Hospitals1,20,779.1155.6112.749.79%20.48%17.27%0.9830.42
MANIPAL HEALTH ENTERPRI L87,926.3997.025.354.07%10.59%9.51%1.1734.66
Max Healthcare83,704.6860.657.397.37%12.18%13.24%0.8433.68
Aster DM Healthcare59,570.09164.2814.164.47%8.48%10.1%1.966.59
Fortis Healthcare58,116.6854.295.876.7%10.53%12.56%0.828.03
Narayana Hrudayalaya35,143.9343.047.746.43%17.17%12.26%2.0719.68
Global Health34,121.9061.788.619.35%14.05%15.26%2.5432.32
Dr. Lal Path Labs31,997.0258.5712.7617.36%20.13%25.56%3.3834.28
KRISHNA INST OF MED SCI L29,480.26151.67.872.51%10.74%7.99%0.6839.1
Syngene International16,251.7287.333.342.79%5.47%7.06%1.2922.34

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

INDEGENE LIMITED Company Background

ISIN
INE065X01017
Sector Market Cap
₹ 14,161.95 Cr

Indegene Limited is an India-based tech-native, life sciences commercialization company. The Company provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. Its segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Brand Activation, and Others. The Enterprise Commercial Solutions business unit caters to the digital marketing operations of life sciences companies. The Enterprise Medical Solutions consolidates large-scale regulatory and medical operations for life sciences companies. The Brand Activation segment offers promotion of biopharmaceutical products and medical devices to HCPs for life sciences companies across channels. It provides customized marketing campaigns through a comprehensive portfolio of proprietary program offerings. Others mainly consist of consultancy and clinical business.

INDEGENE LIMITED Financial Highlights

  • Revenue: INDEGENE LIMITED reported revenue of ₹3,582.50 crore in FY26 vs ₹2,946.50 crore in FY25. It showed an increase of 21.58% on a yearly basis.
  • Operating Profit: INDEGENE LIMITED reported an operating profit of ₹525.00 crore in FY26 vs ₹539.30 crore in FY25. It showed a decrease of 2.65% on a year-on-year basis.
  • Net Profit: INDEGENE LIMITED reported a net profit of ₹401.10 crore in FY26 vs ₹406.70 crore in FY25. It showed a decrease of 1.38% on a yearly basis.

INDEGENE LIMITED Quarterly Result Highlights

  • INDEGENE LIMITED reported revenue of ₹1,137.30 crore in Sep 2026, compared with ₹1,092.10 crore in Jun 2026, representing an increase of 4.14% on a quarter-on-quarter (QoQ) basis.
  • INDEGENE LIMITED reported an operating profit of ₹147.40 crore in Sep 2026, compared with ₹152.70 crore in Jun 2026, representing a decrease of 3.47% on a quarter-on-quarter (QoQ) basis.
  • INDEGENE LIMITED reported a profit of ₹112.30 crore in Sep 2026, compared with ₹116.20 crore in Jun 2026, reflecting a decrease of 3.36% on a QoQ basis.
  • The earnings per share (EPS) of INDEGENE LIMITED stood at ₹16.72 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
0.00%
FII
12.40%
Other DII
3.58%
Retail and other
71.77%
Mutual funds
12.25%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 202511.48%
Mar 202610.27%
Jun 20269.91%
Sep 202612.40%

INDEGENE LIMITED Investment Returns

1 day
-1.12%
1 week
+2.61%
1 month
-0.67%
1 year
+6.29%
3 years
+2.79%
5 years
+2.79%

INDEGENE LIMITED Share Price History

INDEGENE LIMITED share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹594.00 / ₹586.80
-1.12%
29 Oct 26
₹598.95 / ₹593.45
-0.92%
28 Oct 26
₹597.00 / ₹598.95
-0.17%
27 Oct 26
₹601.75 / ₹599.95
-0.30%
Show more

INDEGENE LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹3,510.50₹2,839.30₹2,589.60₹2,306.10
Other Income₹72.00₹107.20₹76.30₹58.00
Total Revenue₹3,582.50₹2,946.50₹2,665.90₹2,364.10
Total Expenses₹3,037.20₹2,407.20₹2,209.70₹2,001.10
Profit Before Tax₹525.00₹539.30₹458.60₹363.00
Tax₹123.90₹132.60₹121.90₹96.90
Profit After Tax₹401.10₹406.70₹336.70₹266.10
EPS - Basic₹16.72₹17.15₹15.19₹12.03
EPS - Diluted₹16.62₹17.02₹15.07₹11.97

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹525.00₹539.30₹458.60₹363.00
Income before WC changes₹652.20₹577.80₹536.80₹454.40
Change in Assets-₹19.60-₹47.70₹1.10-₹174.60
Change in Liabilities₹165.80₹71.80₹94.70-₹41.40
Change in WC₹146.20₹24.10₹95.80-₹216.00
Cash flow from Operations₹650.80₹441.90₹507.70₹130.20
Cash flow from Investing-₹512.40-₹682.70-₹327.20-₹893.30
Cash flow from Financing-₹82.60₹287.50-₹66.20₹333.10
Total Cash Flow₹55.80₹46.70₹114.30-₹430.00
Cash (Start of the year)₹241.00₹188.60₹73.60₹506.30
Cash (End of the year)₹300.80₹241.00₹188.60₹73.60

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹2,001.90₹795.90₹754.80₹755.20
Current Assets₹2,618.40₹2,530.00₹1,790.80₹1,448.70
Total Assets₹4,620.30₹3,325.90₹2,545.60₹2,203.90
Current Liabilities₹1,086.20₹564.50₹610.90₹489.10
Net Current Asset₹1,532.20₹1,965.50₹1,179.90₹959.60
Non-Current Liabilities₹395.40₹145.80₹505.60₹651.00
Equity Capital₹3,138.70₹2,615.60₹1,429.10₹1,063.80
Total Equity & Liabilities₹4,620.30₹3,325.90₹2,545.60₹2,203.90

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,220.60₹1,093.60₹1,045.60₹1,005.70
Other Income₹78.30₹90.40₹50.30₹36.80
Total Revenue₹1,298.90₹1,184.00₹1,095.90₹1,042.50
Total Expenses₹1,017.50₹945.50₹915.30₹865.90
Profit Before Tax₹281.40₹238.50₹180.60₹176.60
Tax₹69.50₹57.20₹42.70₹46.40
Profit After Tax₹211.90₹181.30₹137.90₹130.20
EPS - Basic₹8.83₹7.64₹6.22₹5.89
EPS - Diluted₹8.78₹7.59₹6.17₹5.86

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹281.40₹238.50₹180.60₹176.60
Income before WC changes₹265.60₹198.20₹183.10₹209.40
Change in Assets₹122.20₹9.30-₹3.00-₹107.00
Change in Liabilities₹5.70-₹7.90₹45.40₹21.30
Change in WC₹127.90₹1.40₹42.40-₹85.70
Cash flow from Operations₹345.60₹129.00₹176.20₹81.90
Cash flow from Investing-₹272.10-₹824.70-₹187.70-₹47.90
Cash flow from Financing-₹62.60₹717.30-₹15.80-₹16.90
Total Cash Flow₹10.90₹21.60-₹27.30₹17.10
Cash (Start of the year)₹35.20₹13.20₹41.80₹27.80
Cash (End of the year)₹48.50₹35.20₹13.20₹41.80

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹1,207.00₹931.70₹469.30₹334.80
Current Assets₹1,274.90₹1,218.00₹751.00₹702.90
Total Assets₹2,481.90₹2,149.70₹1,220.30₹1,037.70
Current Liabilities₹273.80₹189.50₹198.10₹169.40
Net Current Asset₹1,001.10₹1,028.50₹552.90₹533.50
Non-Current Liabilities₹127.60₹72.00₹68.40₹73.00
Equity Capital₹2,080.50₹1,888.20₹953.80₹795.30
Total Equity & Liabilities₹2,481.90₹2,149.70₹1,220.30₹1,037.70
* All values are in INR Crore
INDEGENE LIMITED market depth
Bid quantityBid priceAsk priceAsk quantity
00586.82
0000
0000
0000
0000
Total bid quantity0
Total ask quantity2
INDEGENE LIMITED technical summary
Bearish indicators0
Neutral indicators6
Bullish indicators2
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
48.47
Neutral
ATR (14)
18.2
Neutral
STOCH(9,6)
55.07
Neutral
STOCH RSI (14)
46.25
Neutral
ADX(9)
15.82
Bullish
UO(9)
61.3
Neutral
ROC(12)
1.05
Bullish
WillR(14)
-44.93
Neutral
Period
Simple value
Exponential vaue
5D
596.18
591.8
10D
590.8
591.6
20D
591.22
591.24
50D
589.11
582.46
100D
556.05
562.8
Volume trend — traded volume by day
30 Oct7L
29 Oct1L
28 Oct3L
27 Oct7L
26 Oct5L
Average5L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

INDEGENE LIMITED
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in INDEGENE LIMITED

Fund name
AUM
Invesco India Technology Fund
2.93%
SBI Innovative Opportunities Fund
2.09%
Navi Aggressive Hybrid Fund
1.78%

INDEGENE LIMITED Returns Calculator

Ex-date: 31 Jul 2026

INDEGENE LIMITED Latest News

1 month ago
Indegene, PB Fintech, Whirlpool shares spurt amid spike in volumes; check full list
Showing news item 1 of 1

Top Gainers

LAURUSLABS Share Price
₹2405.50
+161.5 (+7.2%)
TRENT Share Price
₹3017.30
+155.6 (+5.44%)
ZYDUSLIFE Share Price
₹1245.50
+61.1 (+5.16%)
NAVINFLUOR Share Price
₹8680.00
+419.5 (+5.08%)
POONAWALLA Share Price
₹461.70
+20.2 (+4.58%)
See more

Top Losers

INTELLECT Share Price
₹504.55
-98.3 (-16.31%)
REDINGTON Share Price
₹326.95
-30.2 (-8.46%)
SUZLON Share Price
₹33.90
-2.89 (-7.86%)
COHANCE Share Price
₹444.30
-37.05 (-7.7%)
PNCINFRA Share Price
₹123.93
-10.05 (-7.5%)
See more

INDEGENE LIMITED Share Price FAQs

Please be aware that INDEGENE LIMITED stock prices are subject to continuous fluctuations due to various factors.